Podcast cover image for The Genetics Podcast Episode 204. The background is orange with faint letters A, C, T, G. On the right is a portrait of Samuli Ripatti wearing glasses and a suit. The title text reads: 'Bringing cardiovascular genetics and biobank discoveries into the clinic.' Below: 'With Samuli Ripatti of the University of Helsinki.' A label in the bottom right corner shows 'Ep 204'.
FinnGen is in the spotlight!
In EP 204 of #TheGeneticsPodcast, Prof. @sripatti.bsky.social, director of @fimm-uh.bsky.social, discusses how FinnGen’s data are helping translate genetics into real-world clinical tools, such as polygenic risk scores & treatment prediction.
🎙️ pod.fo/e/328c49
12.09.2025 07:08 — 👍 3 🔁 3 💬 0 📌 0
Calling all cancer researchers!
Join us, @ohsuknight.bsky.social and @stanford.edu at this year's Early Detection of Cancer Conference for the cutting-edge, cross-disciplinary science that is shaping the future of cancer early detection.
Check out the agenda and register: cruk.ink/3UR67Zu
03.09.2025 11:16 — 👍 12 🔁 12 💬 0 📌 0
Doctoral researcher in generative AI for population health
Doctoral researcher in generative AI for population health
I am hiring! 🎓
We offer a fully funded PhD student position to work on exciting machine learning projects utilizing rich, multimodal real-life health data, based at @fimm-uh.bsky.social in Helsinki, Finland, the happiest country in the world 🇫🇮
jobs.helsinki.fi/job/Helsinki...
Feel free to DM me!
28.08.2025 12:32 — 👍 7 🔁 4 💬 0 📌 1
Kirjastonhoitaja ja Maalivahti: Retrotransposonit pelaavat omilla säännöillään
Päivi Nummi on väitöskirjatutkija Suomen kasvaingenomiikan huippuyksikössä. Hänen tutkimuksensa keskittyy retrotransposoneihin paksu- ja peräsuolen alueen syövissä.
Reissumies retrotransposonit voivat häiritä solun säätelymekanismeja ja edistää syöpiä. Lisää näistä rauhattomista säätelymekanismeja rikkovista retkeilijöistä voit lukea Päivi Nummen kirjottamasta blogikirjoituksesta. @aaltonenlab.bsky.social tumorgenetics.blog/2025/08/26/k...
01.09.2025 08:35 — 👍 0 🔁 0 💬 0 📌 0
Recruitment banner for a Data Scientist position for the FinnGen project. Left: Large FinnGen logo. Right: Black text reads ‘DATA SCIENTIST for the FinnGen project.’ Below are the logos of FIMM and University of Helsinki. Bold black text at the bottom reads ‘APPLY BY 14 SEP.
We are looking for a Data Scientist to support our clinically oriented research teams in generating insights from decades of rich, longitudinal health data. If you are inspired by the opportunity to contribute to cutting-edge research at a global scale, apply here:
jobs.helsinki.fi/job/Helsinki...
21.08.2025 13:25 — 👍 6 🔁 3 💬 0 📌 0
University of Helsinki career ad with a blue chromosome and text: ‘Career Opportunity! Assistant Professor / Associate Professor or Professor of Human Genetics and Genomics. Apply by 10 Oct
The Faculty of Biological and Environmental Sciences of @helsinki.fi invites applications for the position of
🟢 ASSISTANT PROFESSOR / ASSOCIATE PROFESSOR / PROFESSOR OF HUMAN GENETICS AND GENOMICS 🟢
with a possibility of a secondary affiliation with FIMM.
➡️ jobs.helsinki.fi/job/Helsinki...
18.08.2025 07:36 — 👍 2 🔁 4 💬 0 📌 0
Final call: Applications close September 2! KI is recruiting 20 Assistant Professors in a wide range of subject areas. We're looking for early-career researchers with strong scientific merits and future potential. All positions: ki.se/en/about-ki/...
18.08.2025 07:45 — 👍 51 🔁 56 💬 0 📌 2
Valuable discussions at the China-Germany-Finland Life Sciences Forum 2025 at Tampere University.
Our PI Kirsi Rautajoki shared our latest findings on how hypoxia shapes the brain tumor immune environment, representing the Cancer Regulation and Immunology group.
09.08.2025 06:14 — 👍 1 🔁 1 💬 0 📌 0
Portrait of Simone Rubinacci, PhD, smiling with hands folded on a table, in a black shirt against a blue background. To the right is a quote:
"Honestly, FIMM has exceeded my expectations. There’s a genuine openness to new ideas and directions, which has been energising as I build a research program from scratch. Access to rich population-level data has also been a major asset."
Below the quote:
Simone Rubinacci, PhD
FIMM-EMBL Group Leader since 2024
University of Helsinki and FIMM logos appear at the top right.
🚨 2 weeks left!
FIMM @helsinki.fi is hiring new early-career Group Leaders in molecular medicine.
🔬 Population-level genomics + health data
🌍 EMBL partnership
🌳 Nordic life, global science
Run your own lab. Build something bold.
👉 Apply by 10 Aug 2025: jobs.helsinki.fi/job/Helsinki...
28.07.2025 07:57 — 👍 6 🔁 5 💬 0 📌 0
Suomalaistutkijoiden löytö voi paljastaa, miksi rintasyöpä ei aina reagoi immunoterapiaan | Helsingin yliopisto
Suomalaislöytö avaa tien yksilöllisempään syövänhoitoon. Tutkimusmalli kiinnostaa maailmalla.
Immunoterapia on yksi merkittävimmistä edistysaskelista syövän hoidossa, mutta se ei tehoa kaikkiin potilaisiin. Tutkijamme ovat selvittäneet mekanismin, joka voi selittää miksi osa rintasyöpäpotilaista ei hyödy hoidosta odotetusti.
www.helsinki.fi/fi/uutiset/t...
02.06.2025 11:16 — 👍 7 🔁 3 💬 0 📌 0
Our newest paper by Joonas Uusi-Mäkelä et al. about the lncRNAs and their relations on growth and prognosis in diffuse gliomas is out now in Scientific Reports. Study was done in collaboration with NykterLab. www.nature.com/articles/s41...
12.05.2025 10:53 — 👍 3 🔁 3 💬 0 📌 0
Redirecting
A study published in @cp-devcell.bsky.social points to new treatment strategies for the #childhoodcancer #neuroblastoma. Researchers have identified key transcription factor ‘switches’ that can be targeted to lock the cancer into a less aggressive state. #CancerResearch 🧪 doi.org/10.1016/j.de...
12.05.2025 14:40 — 👍 4 🔁 2 💬 0 📌 1
PhD student, Vilja Jokinen from the Tumor Genomics Research group standing next to her poster at this years American Association for Cancer Research (AACR) meeting in Chicago, Illinois! @coeintg.bsky.social #cancerresearch
08.05.2025 10:40 — 👍 1 🔁 1 💬 0 📌 0
The first fruit of our nice collaboration with Susanna Narkilahti's Neurogroup came out in The FASEB journal today, describing a 3D neuron-glioma model and its intercellular interactions. Great work Nanna, Lotta, and others! 👏🙂 dx.doi.org/10.1096/fj.2...
25.04.2025 15:45 — 👍 4 🔁 2 💬 0 📌 0
A platform for life sciences. Publications, research protocols, news, events, jobs and more. Sign up at https://www.lifescience.net.
The Tumor Genomics Group (Aaltonen Lab) focuses on human tumor susceptibility as well as somatic cancer genomics.
Computer scientist, cancer researcher, dad, bioinformatics etc. University of Helsinki. Sanger institute alumn.
Research scientist, applied bioinfomatician. Sports coach.
I am developing machine learning approaches to harness the information contained in the electronic health records, national registries and biobanks for improved disease diagnosis and healthcare resource allocation. Based at FIMM, University of Helsinki.
TerkkoLib is part of Terkko Health Hub. State-of-the-art medical and health information. #HelsinkiHealth publications included. Powered by hulib
A forerunner in the global landscape of genomics research projects. The study has collected and analysed genome and health data from >500,000 Finnish biobank donors to understand the genetic basis of diseases.
www.finngen.fi
FIMM-EMBL Group Leader at @fimm-uh.bsky.social | @mlbiomed.bsky.social | mlbiomed.net
MSc graduate. Senior laboratory technician in #cancergenomics at University of Helsinki. Interests: #science #naturalhistory #beetles #film #games #watercolour
We’re the world's leading independent cancer charity dedicated to saving lives through research, influence and information.
linktr.ee/cr_uk
A molecular medicine research institute focusing on human genomics and precision medicine at HiLIFE, University of Helsinki.
FI: Suomen molekyylilääketieteen instituutti FIMM, Helsingin yliopisto
Website: www.fimm.fi
Assistant (TT) Professor in Translational #gynoncology, Clinician scientist📍University of Helsinki 🇫🇮 Passionate about #precisiononcology #spatialbiology #leadership 🔗 www.farkkilab.org
Group leader at University of Helsinki | Studying ovarian cancer, especially cell fate decisions during emerging treatment resistance |
Science news from the medical university Karolinska Institutet (KI) in Sweden. Our vision is to advance knowledge about life and strive towards better health for all. https://ki.se/
Hyvä elämä ilman syöpää ja syövästä huolimatta – jokaiselle.
Joka kolmas suomalainen sairastuu jossain elämänsä vaiheessa syöpään. Haluamme turvata jokaiselle suomalaiselle hyvän elämän ilman syöpää ja syövästä huolimatta.
Cancer Regulation and Immunology (CRI) research group studies epigenetic and other oncogenic regulation of tumors and tumor microenvironment
Instagram: rautajokilab
https://t.co/1nYs2hxd4a